Sabin Vaccine Institute [to 26 March 2016]
http://www.sabin.org/updates/ressreleases

.
Thursday, March 24, 2016
Amy Finan Appointed Chief Executive Officer of the Sabin Vaccine Institute
WASHINGTON, D.C. —The Sabin Vaccine Institute (Sabin) today announced the appointment of Amy Finan as its next chief executive officer, following a global search by its Board of Trustees.

Finan, currently the senior vice president responsible for business development with the Biotechnology Innovation Organization (BIO), the world’s largest membership organization representing biotechnology companies, academic institutions, and state biotechnology centers, will assume her new role with Sabin on April 18, 2016.

“Amy is an exceptional leader who blends decades of experience in life sciences with the business acumen, advocacy skills, and effective business development and relationship-building abilities required to lead this dynamic and multidimensional non-profit organization,” said Dr. Axel Hoos, chair of the Board of Trustees at Sabin. “Sabin is at the forefront of many of the world’s most pressing health issues and Amy’s record of growth, innovation and partnership development will help to propel the organization into new, exciting territory.”…